New Randomized Study on Hydroxychloroquine Released
The study covers 62 patients and compares 2 groups: one treated with hydroxychloroquine, without azithromycin, and a control / placebo group. After 5 days of
The study covers 62 patients and compares 2 groups: one treated with hydroxychloroquine, without azithromycin, and a control / placebo group. After 5 days of
While high success rates in treating patients tested positive for COVID-19 are achieved in France, using a chloroquine-based treatment, Canadian governmental bodies and professional associations
“Outside of a research protocol, use should be limited to patients whose clinical situation is severe, evaluated on a case-by-case basis, supported by an interdisciplinary
«En dehors d’un protocole de recherche, l’usage devrait être limité à des patients dont la situation clinique est sévère, évaluée au cas par cas, soutenu
The title may seem exaggerated. Yet, it’s based on reality. Canadian research, has opted for self-screening and self-reporting, instead of letting people see a doctor. For
This summarizes pretty well the fate of the hydroxychloroquine azitromycin treatment, while there are numerous research programs now being started, with double blinded protocols. Researchers
There is an interesting opinion piece dated March 26 in the Globe and Mail, suggesting to give the hydroxychloroquine treatment a chance. At the same
Voici une brève analyse des informations disponibles sur les essais cliniques RECOVERY coordonnés par l’Université d’Oxford et pour lesquels les premiers patients ont déjà été
The extremely poorly researched article stresses the need for further research. “Chloroquine seems to block the coronavirus in lab studies. There’s some anecdotal evidence from
According to the website of the “Randomised Evaluation of Covid-19 Therapy” project, there are 4 treatments being tested. See website excerpt below And see critique
See Press Release by UK Government dated March 25 Chloroquine and Hydroxychloroquine not licensed for coronavirus (COVID-19) treatment Recent media reports have suggested that chloroquine
The team of Professor Didier Raoult in Marseille, France, published the first study about the efficacy of hydroxychloroquine, alone or taken with azithromycin, for treating